Optimization of Inpatient Medication Administration among Persons with Parkinson’s disease: Recommendations on Pharmacy Technology and Workflow 

Individuals with Parkinson’s disease (PD) are vulnerable during hospitalizations due to the underlying complexities of symptoms, and acute illness or medication changes often lead to decompensation.

When hospitalized, people with Parkinson’s are at risk of complications resulting from inaccurate medication administration. While hospital pharmacists are not solely responsible for the accuracy of medication administration, they play an integral role in safe pharmacotherapy. Pharmacy-based strategies to reduce hospital complications focus on timely administration of levodopa-containing medications, reducing substitutions and omissions of antiparkinsonian medications, and avoiding antidopaminergic medications. This paper highlights critical areas for improvement and recommendations to minimize the impact of other risk factors from the pharmacy standpoint.




Optimization of Inpatient Medication Administration among Persons with Parkinson’s disease: Recommendations on Pharmacy Technology and Workflow  
Approx. 45 Minutes Read Time | Jeryl Ritzi T. Yu, Brent S. Sokola, and Benjamin L. Walter

Post Article Questions
Graded Quiz







Target Audience

This activity is designed to meet the educational needs of:

  • Physicians
  • Pharmacists
  • Pharmacy Technicians

Learning Objectives

At the end of this activity, learners will be able to:    

  1. Describe the role of pharmacists in inpatient medication management for patients with Parkinson’s.  
  2. Determine the best strategies for reducing the administration of contraindicated medications to people with Parkinson’s.    
  3. Implement strategies for better event reporting and data analysis. 
  4. Integrate acquired knowledge into EMR prescription settings and protocols.    


Course summary
Available credit: 
  • 0.75 ACPE Pharmacy
  • 0.75 AMA PRA Category 1 Credit
Course opens: 
Course expires: 

Parkinson’s Foundation adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

  • All authors of this article have no relevant financial relationships to disclosure. For more details, click here.

In support of improving patient care, Parkinson's Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Parkinson’s Foundation designates this journal activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Pharmacists/Pharmacy Technicians

This activity is approved for 0.75 contact hour(s) ([0.075] CEU) in states that recognize ACPE.
Attending the full program will earn 0.75 contact hour(s).
Universal Activity Number(s):  JA4008310-0000-24-001-H01-P 
Universal Activity Number(s):  JA4008310-0000-24-001-H01-T


Available Credit

  • 0.75 ACPE Pharmacy
  • 0.75 AMA PRA Category 1 Credit
Please login or register to take this course.


Above, you have the ability to purchase individual journals.

To enroll the individual journal above, click "ENROLL". You may proceed with your course from there.

AFTER YOUR ENROLLMENT, you can find the journals you have purchased in your profile or in your email. You can also access them from this page